These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 31002919

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
    Wang H, Chen H, Jin J, Liu Q, Zhong D, Li G.
    Life Sci; 2020 Jun 15; 251():117638. PubMed ID: 32251636
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice.
    Hong P, Li FX, Gu RN, Fang YY, Lai LY, Wang YW, Tao T, Xu SY, You ZJ, Zhang HF.
    Neural Plast; 2018 Jun 15; 2018():9163521. PubMed ID: 29853850
    [Abstract] [Full Text] [Related]

  • 5. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X, Yin D, Ren H, Gao W, Li F, Sun D, Wu Y, Zhou S, Lyu L, Yang M, Xiong J, Han L, Jiang R, Zhang J.
    Neurobiol Dis; 2018 Sep 15; 117():15-27. PubMed ID: 29859317
    [Abstract] [Full Text] [Related]

  • 6. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
    Sui A, Chen X, Shen J, Demetriades AM, Yao Y, Yao Y, Zhu Y, Shen X, Xie B.
    Cell Death Dis; 2020 Oct 22; 11(10):901. PubMed ID: 33093455
    [Abstract] [Full Text] [Related]

  • 7. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.
    Finucane OM, Sugrue J, Rubio-Araiz A, Guillot-Sestier MV, Lynch MA.
    Sci Rep; 2019 Mar 11; 9(1):4034. PubMed ID: 30858427
    [Abstract] [Full Text] [Related]

  • 8. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
    Qu J, Yuan Z, Wang G, Wang X, Li K.
    Int Immunopharmacol; 2019 May 11; 70():147-155. PubMed ID: 30802677
    [Abstract] [Full Text] [Related]

  • 9. Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation.
    Li X, Yao M, Li L, Ma H, Sun Y, Lu X, Jing W, Nie S.
    Phytomedicine; 2024 Jul 11; 129():155578. PubMed ID: 38621328
    [Abstract] [Full Text] [Related]

  • 10. Time-dependent dual effect of NLRP3 inflammasome in brain ischaemia.
    Palomino-Antolin A, Narros-Fernández P, Farré-Alins V, Sevilla-Montero J, Decouty-Pérez C, Lopez-Rodriguez AB, Fernández N, Monge L, Casas AI, Calzada MJ, Egea J.
    Br J Pharmacol; 2022 Apr 11; 179(7):1395-1410. PubMed ID: 34773639
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T, Yoshimatsu G, Sakata N, Kawakami R, Tanaka T, Yamada T, Yoshida Y, Hasegawa S, Kodama S.
    Sci Rep; 2020 Oct 21; 10(1):17920. PubMed ID: 33087823
    [Abstract] [Full Text] [Related]

  • 12. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Huang S, Chen Z, Fan B, Chen Y, Zhou L, Jiang B, Long H, Zhong W, Li X, Li Y.
    J Neuroimmunol; 2021 May 15; 354():577543. PubMed ID: 33714750
    [Abstract] [Full Text] [Related]

  • 13. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
    Zhao J, Guo X, Wang B, Yang Z, Huang T, Guo D, Zhang M, Song J.
    Neurochem Res; 2020 Sep 15; 45(9):2020-2031. PubMed ID: 32474832
    [Abstract] [Full Text] [Related]

  • 14. The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice.
    Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK.
    Brain Behav Immun; 2021 Feb 15; 92():223-233. PubMed ID: 33307174
    [Abstract] [Full Text] [Related]

  • 15. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC.
    J Hepatol; 2017 May 15; 66(5):1037-1046. PubMed ID: 28167322
    [Abstract] [Full Text] [Related]

  • 16. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
    Yaw ACK, Chan EWL, Yap JKY, Mai CW.
    J Cancer Res Clin Oncol; 2020 Sep 15; 146(9):2219-2229. PubMed ID: 32507974
    [Abstract] [Full Text] [Related]

  • 17. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
    Gao R, Shi H, Chang S, Gao Y, Li X, Lv C, Yang H, Xiang H, Yang J, Xu L, Tang Y.
    Int Immunopharmacol; 2019 Sep 15; 74():105575. PubMed ID: 31299609
    [Abstract] [Full Text] [Related]

  • 18. Nlrp3 Inflammasome Inhibitor MCC950 Ameliorates Obliterative Bronchiolitis by Inhibiting Th1/Th17 Response and Promoting Treg Response After Orthotopic Tracheal Transplantation in Mice.
    Xu KY, Tong S, Wu CY, Ding XC, Chen JL, Ming Y, Wang SH.
    Transplantation; 2020 Jun 15; 104(6):e151-e163. PubMed ID: 32108749
    [Abstract] [Full Text] [Related]

  • 19. Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression.
    Wang S, Yao Q, Wan Y, Wang J, Huang C, Li D, Yang B.
    Int J Neurosci; 2020 Mar 15; 130(3):301-308. PubMed ID: 31607194
    [Abstract] [Full Text] [Related]

  • 20. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T, Kritikou E, Venema W, van Duijn J, van Santbrink PJ, Slütter B, Foks AC, Bot I, Kuiper J.
    Arterioscler Thromb Vasc Biol; 2017 Aug 15; 37(8):1457-1461. PubMed ID: 28596375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.